Akebia Therapeutics reported $57.62M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Acadia Pharmaceuticals USD 268.06M 15.94M Mar/2026
Agios Pharmaceuticals USD 18.8M 1.17M Mar/2026
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alnylam Pharmaceuticals USD 1.17B 70M Mar/2026
Amgen USD 8.62B 1.28B Mar/2026
Ardelyx USD 94.47M 30.74M Mar/2026
Astellas Pharma JPY 537.93B 33.28B Mar/2026
AstraZeneca USD 15.29B 213M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
BioMarin Pharmaceutical USD 766M 109M Mar/2026
Celltrion KRW 1.15T 180B Mar/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Exelixis USD 610.8M 12.14M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
GlaxoSmithKline GBP 7.63B 991M Mar/2026
Ionis Pharmaceuticals USD 246M 43M Mar/2026
Ironwood Pharmaceuticals USD 106.51M 58.8M Mar/2026
J&J USD 24.1B 500M Mar/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Karyopharm Therapeutics USD 34.08M 3.54M Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Lexicon Pharmaceuticals USD 5.49M 8.69M Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Moderna USD 389M 289M Mar/2026
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pharma Mar EUR 42.9M 47.3M Mar/2026
Prothena USD 51.08M 51.06M Mar/2026
PTC Therapeutics USD 273M 108.3M Mar/2026
Qiagen NV USD 419.22M 38.16M Mar/2026
Regeneron Pharmaceuticals USD 3.6B 280M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
Sarepta Therapeutics USD 730.8M 287.9M Mar/2026
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Tilray USD 217.51M 74.75M Dec/2025
Vanda Pharmaceuticals USD 198.77M 151.12M Dec/2024
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026